Browsing Tag
Dana Rizk
1 post
Game-changer for kidney disease: Novartis’ Fabhalta wins FDA approval in record time
Novartis has reached a pivotal moment in the treatment of rare kidney diseases with the US Food and…
Business news, market intelligence, and global industry analysis.